National Association of Testing Authorities, Australia
Scope of Accreditation
Pathology Queensland
Site
Public and Environmental Health Reference Laboratories (PEHRL) – Micro/Virology
Accreditation No.
41
Site No.
13096
Date of Accreditation
26 Feb 1998
Address
Coronial and Public Health Sciences (CPHS) , 39 Kessels Road
Coopers Plains, QLD 4108
Australia
Contact
Mrs Michelle Lewis
P: +61 (07) 30962608
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Leptospirosis Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Feb 2028
Last Activity Date
31 Mar 2025
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Leptospira spp. |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Blood; Cerebrospinal fluid (CSF); Serum; Urine | Leptospira spp. |
| Microbiology - Serology of infection - Microbial typing | Serum | Leptospiral agglutination test |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Feb 2028
Last Activity Date
31 Mar 2025
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Shigella spp. |
| Shigella spp. | ||
| Legionella spp. | ||
| Haemophilus spp. | ||
| Salmonella spp.; Salmonella typhi | ||
| Streptococcus pyogenes | ||
| Yersinia enterocolitica | ||
| Neisseria gonorrhoeae | ||
| Haemophilus spp. | ||
| Vibrio spp. | ||
| Neisseria meningitidis | ||
| Streptococcus pneumoniae | ||
| Salmonella spp.; Salmonella typhi | ||
| Streptococcus pneumoniae | ||
| Yersinia enterocolitica | ||
| Legionella spp. | ||
| Bacterial isolates; Faeces | Listeria spp. | |
| Clostridium perfringens | ||
| Faeces | Salmonella typhi | |
| Faeces; Vomitus | Aeromonas spp.; Bacillus cereus; Campylobacter spp.; Clostridium perfringens; Edwardsiella tarda; Escherichia coli - Shiga toxin-producing (STEC); Plesiomonas spp.; Salmonella spp.; Shigella spp.; Staphylococcus aureus; Vibrio spp.; Yersinia spp. |
Molecular Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Feb 2028
Last Activity Date
31 Mar 2025
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Sputum; Tissues; Vomitus | Pathogenic identification and typing |
| Bacterial isolates; Culture isolates; Enrichment broth | Clostridium botulinum type A toxin; Clostridium botulinum type B toxin; Clostridium botulinum type E toxin; Clostridium botulinum type F toxin | |
| Culture isolates; Faeces; Rectal swabs | Clostridium botulinum type A toxin | |
| Faeces | Pathogenic identification and typing | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids by whole genome sequencing | Bacterial isolates; Microbial nucleic acids | Resistance |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Isolates | Viable DNA for sequencing |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Extracted DNA | DNA sequence analysis |
| Microbiology - Molecular biology - Microbial genotyping | Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Isolates; Tissues; Vomitus | Brucella spp.; Neisseria meningitidis; Streptococcus pneumoniae |
| Microbiology - Molecular biology - Microbial genotyping by whole genome sequencing studies | Isolates | Other microbes |
| Microbiology - Molecular biology - Public health investigation and/or monitoring | Bacterial isolates; Microbial nucleic acids | Organism characterisation for patient management; Phylogenetic analysis |
| Faeces | Detection and characterisation of organisms (including identification and typing) |
Virology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
27 Feb 2028
Last Activity Date
31 Mar 2025
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchial washings; Cell culture; Faeces; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabsbronchial | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Blood; Cerebrospinal fluid (CSF); Dry swabs; Isolates; Serum; Tissues; Urine | Nipah virus | |
| Hendra virus | ||
| Henipah group | ||
| Hendra virus | ||
| Blood; Serum | Arenavirus group | |
| Bronchoalveolar lavage; Faeces; Respiratory specimens; Sputum | Human coronavirus MERS ORF1a gene; Human coronavirus MERS UpE gene | |
| Bronchoalveolar lavage; Faeces; Respiratory specimens; Sputum; Tissues | Coronavirus Pan | |
| Cell culture; Faeces; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Cerebrospinal fluid (CSF); Dry swabs | Enterovirus 71 | |
| Enterovirus group | ||
| Cerebrospinal fluid (CSF); Dry swabs; Faeces; Isolates | Enterovirus D68 | |
| Cerebrospinal fluid (CSF); Dry swabs; Isolates; Serum; Tissues; Urine | Measles virus; Measles virus - Vaccine strain | |
| Rubella virus | ||
| Cerebrospinal fluid (CSF); Isolates; Serum; Tissues | Dengue virus 3 | |
| Murray Valley encephalitis virus | ||
| Dengue virus 1 | ||
| Yellow fever virus | ||
| Kunjin virus | ||
| Alphavirus | ||
| Dengue virus - Universal | ||
| Filovirus group | ||
| Dengue virus 4 | ||
| Dengue virus 2 | ||
| Chikungunya virus - Mauritius strain | ||
| West Nile virus | ||
| Zika virus - African strain; Zika virus - Pacific strain E gene | ||
| Dry swabs; Isolates; Tissues | Orthopox virus group | |
| Parapox virus | ||
| Molluscum contagiosum virus | ||
| Orthopox virus group | ||
| Faeces; Serum | Hepatitis A virus (HAV) | |
| Isolates; Serum; Tissues | Rift Valley fever virus | |
| Crimean-Congo hemorrhagic fever virus (CCHF) | ||
| Barmah forest virus | ||
| Ross River virus E gene | ||
| Nasopharyngeal aspirate; Respiratory specimens; Sputum | Influenza A virus H5 | |
| Influenza A virus H3 | ||
| Nasopharyngeal swabs; Respiratory specimens; Sputum | Influenza A virus H1 - 2009 pandemic strain | |
| Influenza B virus - Victoria lineage; Influenza B virus - Yamagata lineage | ||
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Blood; Body fluids; Bronchial washings; Cell culture; Cerebrospinal fluid (CSF); Dry swabs; Faeces; Isolates; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Respiratory specimens; Saliva; Serum; Sputum; Throat swabs; Tissues; Urine; Vomitus | DNA storage for future analyses; Purified PCR product; RNA storage for future analyses; Viable DNA; Viable DNA for sequencing; Viable RNA; Viable RNA for sequencing |
| Microbiology - Molecular biology - Microbial genotyping by whole genome sequencing studies | Nasopharyngeal swabs; Oropharyngeal swabs; Swabs; Throat swabsRespiratory samples | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid IgM antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike S1 antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike S2 antibody |
| Flavivirus IgG; Flavivirus IgM | ||
| Lymphocytic choriomeningitis virus; Rickettsia australis; Rickettsia typhi | ||
| Hepatitis E virus (HEV); Rabies virus | ||
| Alphavirus IgG antibody; Alphavirus IgM antibody; Flavivirus IgM; Hendra virus |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
41
Site No.
13096
Print date
04 Jun 2026
END OF SCOPE